At a glance
Details
Title: Toxicological Profile for 2-Butanone
Subject of Planned Report: The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects for the substance being described.
Purpose of Planned Report: The purpose of the toxicological profile is to provide a source of toxicological and epidemiological data. Data on these hazardous substances supports public health assessment efforts at these sites.
Type of Dissemination: ISI
Timing of Review (including deferrals): May 2018
Type of Review (panel, individual or alternative procedure): Individual
Opportunities for the Public Comment (how and when): A draft was made available for public comment June 2019.
Peer Reviewers Provided with Public Comments before the Review: No
Number of Reviewers: 3
Primary Disciplines or Expertise: toxicology, environmental health, chemistry
Reviewers Selected by (agency or designated outside organization): CDC/ATSDR
Public Nominations Requested for Reviewers: No
Reviewers
Academic and Professional Credentials
Organizational Affiliation(s)
Department of Biochemistry & Molecular Biology, Department of Pathology, University of Texas Medical Branch
Areas of Expertise, Discipline, Relevant Experiences
Expertise / Discipline:
- Molecular toxicology and systems biology
- Biomarker signatures and metabolomics
- Chemical-mediated liver injury and chemical-mediated autoimmunity
Experience:
He has over 120 publications and 5 book chapters. He also received many honors and awards.
Recommended by Scientific/Professional Society or General Public
Academic and Professional Credentials
Organizational Affiliation(s)
Department of Biochemistry, The Vanderbilt University School of Medicine
Areas of Expertise, Discipline, Relevant Experiences
Expertise / Discipline:
- Biochemistry
- Drug metabolism
- Mass spectrometry
- Mutation
- Pharmacology
- Polymorphism
- Spectroscopy
- Toxicology
- Chemistry and enzymology of bioactivation and detoxication of foreign compounds
Experience:
- Mechanisms of activation and detoxication of chemical carcinogens and toxicants
- Characterization of enzymes involved in these processes
- Metabolism of carcinogens and drugs by cytochrome P450 enzymes
- The bioactivation of halogenated hydrocarbons, and polymerase interactions with carcinogen-modified DNA.
Recommended by Scientific/Professional Society or General Public
Academic and Professional Credentials
Current Position Title
Organizational Affiliation(s)
The George Perkins Marsh InstituteClark University
Areas of Expertise, Discipline, Relevant Experiences
Expertise / Discipline:
- Pharmacokinetics
- Risk assessment
- Pharmacodynamics
- Toxicology, toxicity
- Pharmacokinetic modeling
- Pharmacogenetics
- Toxicokinetics
- PKPD modeling
- Human health
Experience:
Dr. Hattis bridges the gap between experimental scientists and statistical researchers by representing the causal mechanisms that are likely to lead to biological damage of policy interest. The principal foci of his past work are the use of various biomarkers and physiologically-based pharmacokinetic models to improve risk assessment for carcinogens; quantitative treatment of inter-individual variability in susceptibility for a wide variety of non-cancer effects; and the use of Monte Carlo simulations to represent the combined effects of multiple sources of uncertainty and variability.
Recommended by Scientific/Professional Society or General Public
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.